New Lantern
AI NativeKeep your eyes on the images. Let AI do the rest. New Lantern the first AI Radiology Resident.
Est 2021|Valuation $74M|Raised $22.6M
Published Sep 19, 2026
| Starting Price | Not public (quote-based) | Not public (quote-based) | Not public (enterprise quote-based) |
| Typical Use Case | Organizations seeking a consolidated cloud-based viewer + worklist + reporting platform | Groups seeking AI-assisted reporting while retaining existing PACS/viewer | Organizations standardized on incumbent dictation/reporting workflows |
| Key Strength | Integrated cloud-native suite with vendor-provided reporting and measurement automation capabilities | Focused reporting assistance; can be layered on top of existing PACS/viewer | Large installed base and mature integrations in many environments |
| Key Weakness | Potential integration constraints with incumbent reporting tools; limited independent review footprint; security posture not fully documented publicly | Primarily a reporting-layer solution (does not replace PACS/viewer) | Legacy complexity and potential migration costs |
—